Complete pathological response following down-staging chemoradiation in locally advanced pancreatic cancer: Challenging the boundaries

World Journal of Gastroenterology

Volumn 13, Issue 47, 2007, Pages 6433-6435

  Khan, Aamir Z ^a   Pitsinis, V ^a   Mudan, S S ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Pancreatic cancer; Pathology

Indexed keywords

CAPECITABINE; DILTIAZEM; GEMCITABINE; OXALIPLATIN;

AGED; AORTA STENOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG CROSS REACTIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; GASTROJEJUNOSTOMY; HEART ATRIUM FIBRILLATION; HEPATOJEJUNOSTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OBSTRUCTIVE JAUNDICE; PANCREAS CANCER; PANCREATICODUODENECTOMY; PROGNOSIS; STENT; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 37649012467     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i47.6433     Document Type: Article

References (15)

1. Kim HJ, Czischke K, Brennan MF, Conlon KC. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg 2002; 6: 763-769
2. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82: 111-115
3. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4: 567-579
4. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004; 198: 722-731
5. Lawrence TS, Chang EY, Hahn TM, Hertel LW, Shewach DS. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys 1996; 34: 867-872
6. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 1993; 217: 144-148
7. Mancuso A, Calabro F, Sternberg CN. Current therapies and advances in the treatment of pancreatic cancer. Crit Rev Oncol Hematol 2006; 58: 231-241
8. Hoffman JP, Cooper HS, Young NA, Pendurthi TK. Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater. J Hepatobiliary Pancreat Surg 1998; 5: 251-254
9. Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, Levy A. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 2000; 135: 81-87; discussion 88
10. Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, Andre T, Zaniboni A, Ducreux M, Aitini E, Taieb J, Faroux R, Lepere C, de Gramont A. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol 2005; 23: 3509-3516
11. Reni M, Cordio S, Milandri C, Passoni P, Bonetto E, Oliani C, Luppi G, Nicoletti R, Galli L, Bordonaro R, Passardi A, Zerbi A, Balzano G, Aldrighetti L, Staudacher C, Villa E, Di Carlo V. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. Lancet Oncol 2005; 6: 369-376
12. Yip D, Goldstein D. Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer. Cancer Treat Rev 2005; 31: 236-241
13. Mornex F, Girard N, Delpero JR, Partensky C. Radiochemotherapy in the management of pancreatic cancer - part I: neoadjuvant treatment. Semin Radiat Oncol 2005; 15: 226-234
14. Dickler A, Abrams RA. Radiochemotherapy in the management of pancreatic cancer - part II: use in adjuvant and locally unresectable settings. Semin Radiat Oncol 2005; 15: 235-244
15. Heidelberger C, Griesbach L, Montag BJ, Mooren D, Cruz O, Schnitzer RJ, Grunberg E. Studies on fluorinated pyrimidines. II. Effects on transplanted tumors. Cancer Res 1958; 18: 305-317